|
시장보고서
상품코드
1907931
암 줄기세포 시장 : 암 유형별, 제품 유형별, 줄기세포 공급원별, 작용 기전별, 용도별, 최종 사용자별, 지역별Cancer Stem Cells Market, By Cancer Type, By Product Type, By Stem Cell Source, By Mode of Action, By Application, By End User, By Geography |
||||||
암 줄기세포 시장은 2025년 33억 4,000만 달러로 평가되었고, 2032년까지 63억 9,000만 달러에 이를 것으로 예측됩니다. 2025-2032년 연평균 복합 성장률(CAGR) 9.7%로 성장할 것으로 전망되고 있습니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2024년 | 시장 규모(2025년) | 33억 4,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2025-2032년 |
| 예측 기간 CAGR(2025-2032년) | 9.70% | 예측 금액(2032년) | 63억 9,000만 달러 |
암 줄기세포(CSC)는 종양 내에서 자가재생 능력과 다계통분화 능력을 가진 독자적인 세포 집단이며 종양학 연구개발에 있어서 중요한 표적이 되고 있습니다. 이러한 세포는 종양 형성의 개시, 전이의 촉진, 치료 저항성의 기여 등의 특성에 의해 정밀암 의료의 최전선에 위치하고 있습니다.
세계의 암 줄기세포 시장은 이러한 파악하기 어려운 세포 집단을 식별, 분리, 표적화하기 위해 설계된 연구 도구, 치료제, 진단 솔루션으로 구성된 종합적인 생태계를 포함하고 있습니다. 이 시장은 유방암, 폐암, 대장암, 뇌종양, 혈액 악성 종양 등 다양한 암종 및 창약, 바이오마커 식별, 맞춤형 치료 전략 등 폭넓은 용도 분야를 가지고 있습니다. CSC의 생물학에 대한 이해의 심화는 유동 세포 계측 시스템, 세포 배양 배지, 항체, 저분자 억제제 등 전문 기술에 대한 엄청난 투자를 촉진합니다.
시장 역학
세계의 암 줄기세포 시장은 그 확대 및 기술적 진보를 가속시키는 여러 주요 시장 성장 촉진요인에 의해 견인되고 있습니다. 주요 성장 요인은 세계적으로 암 부담이 지수적으로 증가하고 있다는 것입니다. 연간 1,900만 건이 넘는 신규 사례가 진단되고 있는 가운데, 치료 저항성 및 종양 재발에 대처하는 혁신적인 치료 접근법에 대한 긴급 수요가 발생하고 있습니다.
정부기관, 제약기업, 생명공학 기업에 의한 암 연구에 대한 많은 투자는 CSC 관련 연구의 자금 조달 가능성을 크게 높여주고 있습니다. 한편, 줄기세포 생물학 및 암 병태에 있어서의 획기적인 발견은 창약과 맞춤형 의료 어프로치의 새로운 길을 열었습니다. 단일 세포 시퀀싱, CRISPR 유전자 편집, 고급 세포 선별 시스템과 같은 첨단 기술 플랫폼은 CSC 연구 능력에 혁명을 일으켜 이러한 세포 집단의 보다 정확한 식별 및 특성화를 가능하게 합니다.
그러나 시장의 성장에는 현저한 제약이 존재합니다. 전문적인 연구 장비 및 시약의 높은 비용은 소규모 연구 기관 및 개발 도상 지역에서의 접근을 제한할 수 있습니다. CSC의 희소성과 표현형의 가소성에 의한 분리 및 특성 평가의 기술적 과제는 연구자에게 중대한 장벽이 되고, CSC 표적 치료제에 대한 엄격한 규제 요건은 개발 기간의 연장과 비용 증가를 초래하고 있습니다.
이러한 과제가 있음에도 불구하고 시장에는 큰 기회가 있습니다. 구체적으로는 조기 암 검출 및 모니터링을 위한 액체 생검 개발에 있어서의 새로운 용도, CSC가 중요한 역할을 하는 희소 암종에 대한 연구 확대, 생체내 종양 환경을 보다 충실히 재현하는 3D 세포 배양 및 오가노이드 기술의 보급 확대 등을 들 수 있습니다. 종양세포 전체와 암 줄기세포 집단의 양쪽을 표적으로 하는 병용 요법에 대한 주목도 증가와 바이오마커 발견 프로그램에 대한 투자 증가가 함께 향후 수년간 시장의 지속적인 성장과 혁신이 기대됩니다.
이 보고서의 주요 특징
- 본 보고서는 세계의 암 줄기세포 시장을 상세하게 분석하여 2024년을 기준 연도로 한 예측 기간(2025-2032년) 시장 규모 및 CAGR을 제공합니다.
- 또한 각 부문의 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인 및 억제요인과 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
- 세계 암 줄기세포 시장의 주요 기업 프로파일을 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 다음 파라미터에 근거하여 제공합니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자 및 기업 경영진은 향후 제품 출시, 제휴, 시장 확대, 마케팅 전술에 대한 충분한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- '세계의 암 줄기세포 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
- 이해관계자는 세계의 암 줄기세포 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적 및 전제조건
- 분석 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의 및 범위
- 주요 요약
제3장 시장 역학, 규제 및 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 출시 및 승인
- PEST 분석
- Porter's Five Forces 분석
- 기업 합병 및 인수(M&A) 시나리오
- 업계 동향
제4장 세계의 암 줄기세포 시장 : 암 유형별(2020-2032년)
- 유방암
- 혈액암
- 폐암
- 뇌종양
- 대장암
- 췌장암
- 방광암
- 간암
- 기타 암의 유형
제5장 세계의 암 줄기세포 시장 : 제품 유형별(2020-2032년)
- 세포 배양 제품
- 세포 분리 제품
- 세포 분석 제품
- 분자 분석 제품
- 기타 보조 도구 및 시약(예 : 배지, 마커, 분석 키트)
제6장 세계의 암 줄기세포 시장 : 줄기세포 공급원별(2020-2032년)
- 골수 유래
- 말초혈 유래
- 제대혈 유래
- 인공 다능성 줄기세포(iPS세포)
제7장 세계의 암 줄기세포 시장 : 작용 기전별(2020-2032년)
- 표적형 암 줄기세포 치료
- 면역요법에 근거한 접근
- 기타(화학요법 내성 역전제)
제8장 세계의 암 줄기세포 시장 : 용도별(2020-2032년)
- 연구개발
- 바이오마커 식별
- 창약 및 스크리닝
- 종양 형성 연구
- 진단 용도
- 암 예후
- 미소 잔존 병변의 검출
- 치료 용도
- 임상 치료
- 보조 요법
제9장 세계의 암 줄기세포 시장 : 최종 사용자별(2020-2032년)
- 병원, 암 치료 센터
- 제약회사, 바이오테크놀러지 기업
- 학술기관 및 연구기관, 연구소
- 의약품 개발 업무 수탁 기관(CRO)
- 기타 최종 사용자(세포 뱅크, 진단센터)
제10장 세계의 암 줄기세포 시장 : 지역별(2020-2032년)
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카 국가
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동 국가
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제11장 경쟁 구도
- Lineage Cell Therapeutics, Inc.
- FUJIFILM Irvine Scientific
- Thermo Fisher Scientific Inc.
- Merck KGaA
- MacroGenics, Inc.
- Miltenyi Biotec
- AbbVie Inc.
- STEMCELL Technologies Inc.
- Bionomics
- Sino Biological Inc.
- Celgene Corporation
- Incyte Corporation
- Novartis AG
- Pfizer Inc.
- Lonza Group AG
제12장 애널리스트의 제안
- 기회
- 애널리스트의 견해
- 일관된 기회 지도(COM)
제13장 참고문헌 및 분석 방법
- 참고문헌
- 분석 방법
- Coherent Market Insights에 대해
Cancer Stem Cells Market is estimated to be valued at USD 3.34 Bn in 2025 and is expected to reach USD 6.39 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.7% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3.34 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 9.70% | 2032 Value Projection: | USD 6.39 Bn |
Cancer stem cells (CSCs) represent a unique subpopulation of cells within tumors that possess self-renewal capabilities and multilineage differentiation potential, making them critical targets in oncology research and therapeutic development. These cells are characterized by their ability to initiate tumor formation, drive metastasis, and contribute to treatment resistance, positioning them at the forefront of precision cancer medicine.
The global cancer stem cells market encompasses a comprehensive ecosystem of research tools, therapeutic agents, and diagnostic solutions designed to identify, isolate, and target these elusive cellular populations. This market spans various cancer types including breast, lung, colorectal, brain, and hematological malignancies, with applications extending across drug discovery, biomarker identification, and personalized treatment strategies. The increasing understanding of CSC biology has catalyzed significant investments in specialized technologies such as flow cytometry systems, cell culture media, antibodies, and small molecule inhibitors.
Market Dynamics
The global cancer stem cells market is propelled by several key drivers that collectively accelerate its expansion and technological advancement. The primary growth catalyst stems from the exponentially increasing global cancer burden, with over 19 million new cases diagnosed annually, creating urgent demand for innovative therapeutic approaches that address treatment resistance and tumor recurrence.
Substantial investments in cancer research by government agencies, pharmaceutical companies, and biotechnology firms have significantly enhanced funding availability for CSC-related studies, while breakthrough discoveries in stem cell biology and cancer pathogenesis have opened new avenues for drug development and personalized medicine approaches. Advanced technological platforms including single-cell sequencing, CRISPR gene editing, and sophisticated cell sorting systems have revolutionized CSC research capabilities, enabling more precise identification and characterization of these cellular populations.
However, market growth faces notable restraints including the high costs associated with specialized research equipment and reagents, which can limit accessibility for smaller research institutions and developing regions. Technical challenges in CSC isolation and characterization due to their rarity and phenotypic plasticity create significant barriers for researchers, while stringent regulatory requirements for CSC-targeting therapeutics extend development timelines and increase costs.
Despite these challenges, the market presents substantial opportunities through emerging applications in liquid biopsy development for early cancer detection and monitoring, expanding research into rare cancer types where CSCs play critical roles, and growing adoption of 3D cell culture and organoid technologies that better recapitulate in vivo tumor environments. The increasing focus on combination therapies targeting both bulk tumor cells and cancer stem cell populations, coupled with rising investments in biomarker discovery programs, positions the market for sustained growth and innovation in the coming years.
Key Features of the Study
- This report provides in-depth analysis of the global cancer stem cells market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cancer stem cells market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Lineage Cell Therapeutics, Inc., FUJIFILM Irvine Scientific, Thermo Fisher Scientific Inc., Merck KGaA, MacroGenics, Inc., Miltenyi Biotec, AbbVie Inc., STEMCELL Technologies Inc., Bionomics, Sino Biological Inc., Celgene Corporation, Incyte Corporation, Novartis AG, Pfizer Inc., and Lonza Group AG
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cancer stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cancer stem cells market
Market Segmentation
- Cancer Type Insights (Revenue, USD Bn, 2020 - 2032)
- Breast Cancer
- Blood Cancer
- Lung Cancer
- Brain Cancer
- Colorectal Cancer
- Pancreatic Cancer
- Bladder Cancer
- Liver Cancer
- Other Cancer Types
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Cell culturing products
- Cell separation products
- Cell analysis products
- Molecular analysis products
- Other supporting tools/reagents (e.g. media, markers, assay kits)
- Stem-cell Source Insights (Revenue, USD Bn, 2020 - 2032)
- Bone Marrow-derived
- Peripheral Blood-derived
- Umbilical Cord Blood-derived
- Induced Pluripotent Stem Cells (iPSCs)
- Mode of Action Insights (Revenue, USD Bn, 2020 - 2032)
- Targeted Cancer Stem Cell Therapies
- Immunotherapy-based Approaches
- Others (Chemotherapy Resistance Reversal Agents)
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Research and Development
- Biomarker Identification
- Drug Discovery and Screening
- Tumorigenesis Studies
- Diagnostic Applications
- Cancer Prognosis
- Minimal Residual Disease Detection
- Therapeutic Applications
- Clinical Treatment
- Adjunct Therapy
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals and cancer treatment centers
- Pharmaceutical and biotechnology companies
- Academic and research institutes/laboratories
- Contract research organizations (CROs)
- Other end users (Cell banks, diagnostic centers)
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Lineage Cell Therapeutics, Inc.
- FUJIFILM Irvine Scientific
- Thermo Fisher Scientific Inc.
- Merck KGaA
- MacroGenics, Inc.
- Miltenyi Biotec
- AbbVie Inc.
- STEMCELL Technologies Inc.
- Bionomics
- Sino Biological Inc.
- Celgene Corporation
- Incyte Corporation
- Novartis AG
- Pfizer Inc.
- Lonza Group AG
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Cancer Stem Cells Market, By Cancer Type
- Global Cancer Stem Cells Market, By Product Type
- Global Cancer Stem Cells Market, By Stem Cell Source
- Global Cancer Stem Cells Market, By Mode of Action
- Global Cancer Stem Cells Market, By Application
- Global Cancer Stem Cells Market, By End User
- Global Cancer Stem Cells Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Cancer Stem Cells Market, By Cancer Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Blood Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Brain Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Colorectal Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pancreatic Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Bladder Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other Cancer Types
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Cancer Stem Cells Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Cell culturing products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cell separation products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cell analysis products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Molecular analysis products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other supporting tools/reagents (e.g. media, markers, assay kits)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Cancer Stem Cells Market, By Stem Cell Source, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Bone Marrow-derived
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Peripheral Blood-derived
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Umbilical Cord Blood-derived
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Induced Pluripotent Stem Cells (iPSCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Cancer Stem Cells Market, By Mode of Action, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Targeted Cancer Stem Cell Therapies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Immunotherapy-based Approaches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Chemotherapy Resistance Reversal Agents)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Cancer Stem Cells Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biomarker Identification
- Drug Discovery and Screening
- Tumorigenesis Studies
- Diagnostic Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cancer Prognosis
- Minimal Residual Disease Detection
- Therapeutic Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Clinical Treatment
- Adjunct Therapy
9. Global Cancer Stem Cells Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals and cancer treatment centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Pharmaceutical and biotechnology companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Academic and research institutes/laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Contract research organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other end users (Cell banks, diagnostic centers)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Cancer Stem Cells Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Cancer Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Stem Cell Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mode of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Cancer Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Stem Cell Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mode of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Cancer Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Stem Cell Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mode of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Cancer Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Stem Cell Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mode of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Cancer Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Stem Cell Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mode of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Cancer Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Stem Cell Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Mode of Action, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Lineage Cell Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- FUJIFILM Irvine Scientific
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MacroGenics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Miltenyi Biotec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- STEMCELL Technologies Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bionomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sino Biological Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Celgene Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Incyte Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
